Effective Date: 1/04
|
|
- Julian Bruce
- 8 years ago
- Views:
Transcription
1 North Shore-Long Island Jewish Health System Long Island Jewish Medical Center POLICY TITLE: Prepared by: System Pharmacy & Therapeutics Committee Effective 1/04 PATIENT CARE MANUAL Last Reviewed / Revised: 1/04, 10/07, 11/08, 5/10, 4/12, 9/13, 7/14 Total Pages: 10 GENERAL STATEMENT OF PURPOSE: High-alert medications are those drugs that bear a heightened risk of causing significant patient harm when used in error. Though mistakes may or may not be more common with these agents, the consequences of such an error carry the potential for devastating outcomes. The Joint Commission (TJC) Medication Management (MM) standards require institutions to identify, in writing, its high-alert medications, develop a process for managing high-alert medications, and implement its process. POLICY: Identify and review a list of high-alert drugs specific to the North Shore LIJ Health System. This list will be used to ensure that safeguards are put in place to prevent medication errors and protect the patient. SCOPE: This policy applies to all members of the North Shore LIJ Health System work force but not limited to employees, business associates, medical staff, volunteers, students, physician office staff, and other persons performing work for or at North Shore LIJ Health System. PROCEDURE / GUIDELINES: The System P&T Committee has agreed to designate the following drug pairs as North Shore LIJ Health System high-alert medications (see Appendix I). Requests to add or remove agents from this list will be directed to the System P&T Committee. The ultimate decision to modify this policy shall lie with the System P&T Committee membership. Due to differing medication management processes at each Health System site and the implementation of various technology solutions, the exact strategies (i.e. processes) for managing high-alert medications shall be determined by local P&T Committees (see Appendix II). Recommended strategies may include, but are not limited to: Standardizing the ordering, storage, preparation, and administration of these products Improving access to information about these drugs Limiting access to high-alert medications Using auxiliary labels and automated alerts Employing redundancies such as automated or independent double-checks Document: Reviewed/Revised July 2014 Page 1/10
2 LIJMC HIGH-ALERT MEDICATION MANAGEMENT STRATEGIES: Storage: Auxiliary labels and other visual cues (e.g., red bins) are used to identify high-alert agents whenever possible Transcription / Ordering: High Alert Medications approved by the System P&T Committee will be configured in Enterprise Sunrise. All adult orderables for these agents will be flagged as High Alert to alert all health care providers. Preparing / Dispensing: Concentrations and/or doses are standardized whenever possible Administration: Smart pumps are utilized for continuous IV infusions whenever possible Administration guidelines are standardized (e.g., IV admixture guide) Monitoring: Continuous tracking, trending and analysis of suspected drug reactions and medication errors are performed. Assessment of the effectiveness of the implemented high-alert medication strategies in the promotion of patient safety via the prevention of medication errors is ongoing through both the Medication Safety and the Pharmacy and Therapeutics Committees. Reporting of suspected drug reactions and medication errors to the Department of Quality Management and the Performance Improvement Coordinating Group is maintained on a monthly basis, with appropriate action taken as necessary. REFERENCES: The Joint Commission s Hospital Accreditation Standards Medication Management ISMP s List of Document: Reviewed/Revised July 2014 Page 2/10
3 Reviewed / Approved by: LIJMC Pharmacy & Therapeutics Committee 07/09/14 Reviewed / Approved by: LIJMC Medical Board 07/22/14 SIGNATURES: Richard Schwarz, Medical Director (LIJ) Margaret Murphy, Chief Nursing Officer (LIJ) Joseph Simpson, Chair, Pharmacy & Therapeutics Committee (LIJ) Dana Rucco, Director of Pharmacy Services (LIJ) Blaine Greenwald, Acting Medical Director (ZHH) Mary Beth McManus, Associate Executive Director I, PCS (ZHH) Neil Kremen, Chair, Pharmacy & Therapeutics Committee (ZHH) Anthony Longo, Director of Pharmacy Services (ZHH) Document: Reviewed/Revised July 2014 Page 3/10
4 Reviewed/Revised July 2014 Page 4/10
5 Reviewed/Revised July 2014 Page 5/10
6 Reviewed/Revised July 2014 Page 6/10
7 Reviewed/Revised July 2014 Page 7/10
8 Reviewed/Revised July 2014 Page 8/10
9 Reviewed/Revised July 2014 Page 9/10
10 Reviewed/Revised July 2014 Page 10/10
Improving Medication Errors and Near Miss Reporting Without Spending Money. Jacob Thompson, PharmD, MS Associate Director of Pharmacy
Improving Medication Errors and Near Miss Reporting Without Spending Money Jacob Thompson, PharmD, MS Associate Director of Pharmacy Learning Objectives Describe strategies to improve medication errors
More informationSafetyFirst Alert. Errors in Transcribing and Administering Medications
SafetyFirst Alert Massachusetts Coalition for the Prevention of Medical Errors January 2001 This issue of Safety First Alert is a publication of the Massachusetts Coalition for the Prevention of Medical
More informationCHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE)
CHAPTER 61-03-02 CONSULTING PHARMACIST REGULATIONS FOR LONG-TERM CARE FACILITIES (SKILLED, INTERMEDIATE, AND BASIC CARE) Section 61-03-02-01 Definitions 61-03-02-02 Absence of Provider or Consulting Pharmacist
More informationCENTRAL IOWA HEALTHCARE Marshalltown, Iowa PHARMACY POLICY AND PROCEDURE
CENTRAL IOWA HEALTHCARE Marshalltown, Iowa PHARMACY POLICY AND PROCEDURE Policy #: MM.01.01.03 Subject: High Alert and Hazardous Medications (including pharmaceutical waste management) Purpose: The hospital
More informationMEDICATION MANUAL Policy & Procedure
MEDICATION MANUAL Policy & Procedure TITLE: High Alert Medication NUMBER: MM 50-010 Effective Date: September 13, 2013 Page 1 of 6 Applies To: Holders of Medication Manual This policy is applicable to
More informationPrepublication Requirements
Issued December 18, 2013 Prepublication Requirements The Joint ommission has approved the following revisions for prepublication. While revised requirements are published in the semiannual updates to the
More informationCORONER S REPORT REPORT
CORONER S REPORT 26 THE CORONER HAS RECOMMENDED THAT THE ONTARIO COLLEGE OF PHARMACISTS EDUCATE CLINICIANS ON THE DEFINITION OF OPIOID TOLERANCE, AND REVIEW THE PATIENT CONDITIONS AND COMORBIDITIES THAT
More informationThe Massachusetts Coalition for the Prevention of Medical Errors. MHA Best Practice Recommendations to Reduce Medication Errors
The Massachusetts Coalition for the Prevention of Medical Errors MHA Best Practice Recommendations to Reduce Medication Errors Executive Summary In 1997, the Massachusetts Coalition for the Prevention
More informationSafe IV Compounding Procedures: The Release of ISMP Guidelines
Safe IV Compounding Procedures: The Release of ISMP Guidelines Matthew P. Fricker, Jr., MS, RPh, FASHP, Program Director Institute for Safe Medication Practices 1 Objectives List system based causes of
More informationDISPENSING HIGH RISK/ALERT MEDICATIONS. Lana Gordineer, MSN, RN Diabetes Educator
DISPENSING HIGH RISK/ALERT MEDICATIONS Lana Gordineer, MSN, RN Diabetes Educator HIGH RISK/ALERT MEDICATIONS (or DRUGS) Medications that have a high risk of causing serious injury or death to a patient
More informationTransforming the pharmacy into a strategic asset
Transforming the pharmacy into a strategic asset Improving productivity through automation optimization 700-bed integrated delivery system in the South Success snapshot When a hospital invests heavily
More informationBOARD OF PHARMACY DIVISION 41 OPERATION OF PHARMACIES (RETAIL AND INSTITUTIONAL DRUG OUTLETS) CONSULTING PHARMACISTS AND OPERATION OF DRUG ROOMS
BOARD OF PHARMACY DIVISION 41 OPERATION OF PHARMACIES (RETAIL AND INSTITUTIONAL DRUG OUTLETS) CONSULTING PHARMACISTS AND OPERATION OF DRUG ROOMS 855-041-6050 Definitions Hospitals with Pharmacies (1) In
More informationInstitute for Safe Medication Practices
Institute for Safe Medication Practices 1800 Byberry Road, Suite 810 Huntingdon Valley, PA 19006 FOR MORE INFORMATION, CONTACT : Michael A. Donio, MPA Marketing & Consumer Affairs 215-947-7797 Mdonio@ismp.org
More informationOverview of emar Electronic Medication Administration Record
Overview of emar Electronic Medication Administration Record March 2006 WHAT IS emar? emar Electronic Medication Administration Record - Replaces the paper MAR MAK Medication Administration Check (Siemens)
More informationSUPPLEMENTAL HANDOUT FOR INPATIENT PHARMACISTS
The main navigation buttons at the bottom of each screen allows you to Pause/Play, Advance, and Go Back. The Pause/Play button will flash to let you know you can advance to the next screen. There is no
More informationHEALTH REQUIREMENTS & SERVICES: MEDICAL TREATMENT
DESCRIPTOR TERM: Students Millard District Policy File Code: 6200 1 st Reading: 05-08-14 HEALTH REQUIREMENTS & SERVICES: MEDICAL TREATMENT Purpose The purpose of this policy is to authorize school personnel
More informationAn introduction to High Risk Medications
An introduction to High Risk Medications Une politique sure des médicaments : déjà deux approches 25 octobre 2013 Danguy Christine Hôpital A. Vésale An introduction to High Risk Medications 1. High Risk
More informationNational Patient Safety Agency. Risk Assessment of Injectable Medicines. STEP 1 Local Risk Factor Assessment. STEP 2 Product Risk Factor Assessment
NPSA Injectable Medicines Risk Assessment Tool National Patient Safety Agency Risk Assessment of Injectable Medicines STEP 1 Local Risk Factor Assessment. Carry out a baseline assessment in a near patient
More informationPharmacy Program Pre-Test
Last Name: Pharmacy Program Pre-Test * For each question, put a check mark for the one option that you think is correct. 1. A pharmacist receives a security prescription from a known local medical group
More informationPROPOSAL FOR INTEGRATION OF ICU MEDICAL DEVICES WITH ELECTRONIC MEDICAL RECORD
PROPOSAL FOR INTEGRATION OF ICU MEDICAL DEVICES WITH ELECTRONIC MEDICAL RECORD Presented on November 2011 to the Community Health Center Board of Directors Presented by: Jeana O Brien Sharon Perelman Maureen
More informationNew and Emerging Roles for Pharmacy Staff
New and Emerging Roles for Pharmacy Staff Marie Slimm, Chief Pharmacy Technician Pharmacy Technicians Support the Administration of I.V s Marie Slimm, Chief Pharmacy Technician 1 There is no conflict of
More informationChallenges of the Cartfill and Cartless Models of Drug Distribution
Challenges of the Cartfill and Cartless Models of Drug Distribution November 2007 Richard D. Caldwell, RPh, MS Abstract Hospital pharmacies are responsible for ensuring that every step of the medication
More informationNARCOTIC AND CONTROLLED DRUG MANAGEMENT
NARCOTIC AND CONTROLLED DRUG MANAGEMENT LHSC Policy available on the intranet at: http://appserver.lhsc.on.ca/policy/search_res.php? polid=pcc019&live=1 STAFF ADMINISTERING NARCOTICS: Manage area drug
More informationThe Brigham and Women s Hospital Department of Pharmacy
Using Bar Code Verification to Improve Patient Care and Tracking and Traceability William W. Churchill MS, R.Ph. Chief of Pharmacy Services Brigham and Women s Hospital The Brigham and Women s Hospital
More informationAdministrative Policies and Procedures for MOH hospitals /PHC Centers. TITLE: Organization & Management Of Medication Use APPLIES TO: Hospital-wide
Administrative Policies and Procedures for MOH hospitals /PHC Centers TITLE: Organization & Management Of Medication Use APPLIES TO: Hospital-wide NO. OF PAGES: ORIGINAL DATE: REVISION DATE : السیاسات
More informationCONNECTICUT. Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION
CONNECTICUT Downloaded January 2011 19 13 D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION (d) General Conditions. (6) All medications shall be administered only by licensed
More informationHIGH PERFORMANCE PHARMACY SM
HIGH PERFORMANCE PHARMACY SM The 8 Dimensions of the High Performance Pharmacy for High Performance SM Pharmacy Education Human Resources Management Leadership Medication Preparation and Delivery Performance
More informationMedication Guidelines
Medication Guidelines January 2014 Approved by the College and Association of Registered Nurses of Alberta Provincial Council, January 2014. Second printing with editorial change (p16), November 2014.
More informationReducing the risk of patient harm: A focus on insulin
Reducing the risk of patient harm: A focus on insulin New York State Partnership for Patients (NYSPFP) Initiative Regional Educational Session November 2013 1 1 Disclosure Matt Fricker, Matt Grissinger,
More informationOffice of Clinical Standards and Quality / Survey & Certification Group
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services 7500 Security Boulevard, Mail Stop C2-21-16 Baltimore, Maryland 21244-1850 Office of Clinical Standards and Quality / Survey
More informationPHARMACY TECHNICIAN STRUCTURED PRACTICAL TRAINING (SPT) - GUIDE
PHARMACY TECHNICIAN STRUCTURED PRACTICAL TRAINING (SPT) - GUIDE Goals This structured practical training program is intended to ensure candidates understand and meet the competencies and standards of practice
More informationMedication Safety and Error Prevention
Medication Safety and Error Prevention 16 LEARNING OBJECTIVES By the end of this chapter, students will be able to competently: 1. Explain the process for reporting errors. 2. Explain the difference between
More informationGUIDELINES ON PREVENTING MEDICATION ERRORS IN PHARMACIES AND LONG-TERM CARE FACILITIES THROUGH REPORTING AND EVALUATION
GUIDELINES GUIDELINES ON PREVENTING MEDICATION ERRORS IN PHARMACIES AND LONG-TERM CARE FACILITIES THROUGH REPORTING AND EVALUATION Preamble The purpose of this document is to provide guidance for the pharmacist
More informationPathways for Medication Safety. Looking. Collectively. At Risk. A Partnership: American Hospital Association. Health Research and Educational Trust
Pathways for Medication Safety SM Looking Collectively At Risk A Partnership: American Hospital Association Health Research and Educational Trust Institute for Safe Medication Practices Pathways for Medication
More informationKey Element V: Drug Standardization, Storage, and Distribution
Key Element V: Drug Standardization, Storage, and Distribution Prescribed medications are accessible to patients and dispensed in a safe and secure manner. Medications and other necessary drug supplies
More informationInsulin: A Practice Update. Department of Nursing Staff Development Elizabeth Borgelt, MS, RN
Insulin: A Practice Update Department of Nursing Staff Development Elizabeth Borgelt, MS, RN Learning Outcome The learner will be able to identify the different types of insulins available, their actions,
More informationfor HOSPITALS ISMP MEDICATION SAFETY SELF ASSESSMENT THE 2004 A quality improvement workbook for study participants PRELIMINARY COMPARATIVE DATA FROM
PRELIMINARY COMPARATIVE DATA FROM THE 2004 ISMP MEDICATION SAFETY SELF ASSESSMENT for HOSPITALS A quality improvement workbook for study participants Institute for Safe Medication Practices Limited distribution
More informationPharmacy Practice in U.S. Hospitals. Douglas Scheckelhoff, MS, FASHP Vice President Practice Advancement
Pharmacy Practice in U.S. Hospitals Douglas Scheckelhoff, MS, FASHP Vice President Practice Advancement Objectives Discuss ASHP and its mission Discuss the goals of hospital pharmacy Describe the historical
More informationRULE. The Administration of Medication in Louisiana Public Schools
RULE The Administration of Medication in Louisiana Public Schools Developed in 1994 by The Louisiana State Board of Elementary and Secondary Education and The Louisiana State Board of Nursing Amendments
More information105 CMR: DEPARTMENT OF PUBLIC HEALTH 105 CMR 210.000: THE ADMINISTRATION OF PRESCRIPTION MEDICATIONS IN PUBLIC AND PRIVATE SCHOOLS
105 CMR 210.000: THE ADMINISTRATION OF PRESCRIPTION MEDICATIONS IN PUBLIC AND PRIVATE SCHOOLS Section 210.001: Purpose 210.002: Definitions 210.003: Policies Governing the Administration of Prescription
More informationPolicies and Procedures. Number: 1127
Policies and Procedures Title: NARCOTIC CONTROL: DOCUMENTATION AND COUNT Authorization: [X] Pharmacy/Nursing Committee [X] SHR Nursing Practice Committee Number: 1127 Source: Pharmacy/Nursing Cross Index:
More informationIT requirement specification Safety alert. Oral methotrexate 2.5mg and 10mg tablets
IT requirement specification Safety alert Oral methotrexate 2.5mg and 10mg tablets Synopsis This document sets out the IT requirements for addressing methotrexate-related patient safety incidents that
More informationHow To Prevent Medication Errors
The Academy of Managed Care Pharmacy s Concepts in Managed Care Pharmacy Medication Errors Medication errors are among the most common medical errors, harming at least 1.5 million people every year. The
More informationTABLE OF CONTENTS CHAPTER 9 PATIENT COUNSELING AND PROSPECTIVE DRUG USE REVIEW REGULATIONS
TABLE OF CONTENTS CHAPTER 9 PATIENT COUNSELING AND PROSPECTIVE DRUG USE REVIEW REGULATIONS Section 1. Authority 9-1 Section 2. Definitions 9-1 Section 3. Patient Profile Records 9-1 Section 4. Prospective
More informationPharmacy Technician A. Interpersonal Skills Physical Effort Concentration Complexity
Job Class Profile: Pharmacy Technician A Pay Level: CG-28 Point Band: 578-621 Accountability & Decision Making Development and Leadership Environmental Working Conditions Factor Knowledge Interpersonal
More informationAdverse reactions identification and documentation
Adverse reactions identification and documentation Contents Purpose... 1 Policy... 2 Scope... 2 Associated documents... 2 Responsibilities on Presentation to the CDHB for capture and documentation... 3
More informationEffective Date: 6/3/14
North Shore-Long Island Jewish Health System, Inc. Long Island Jewish Medical Center PATIENT CARE SERVICES POLICY TITLE: ORDERING, ADMINISTRATION AND DISPOSAL OF ORAL CHEMOTHERAPEUTIC AGENTS Prepared by:
More informationExample of a Health Care Failure Mode and Effects Analysis for IV Patient Controlled Analgesia (PCA) Failure Modes (what might happen)
Prescribing Assess patient Choose analgesic/mode of delivery Prescribe analgesic Institute for Safe Medication Practices Example of a Health Care and Effects Analysis for IV Patient Controlled Analgesia
More informationCommunity Pharmacies
High-Alert Medication Modeling and Error-Reduction Scorecards (HAMMERS ) Workbook For Community Pharmacies Data Entry Errors (Patient) Data Entry Errors (Drug) Prescribing Errors Point of Sale Errors Drug
More informationSUNY DOWNSTATE MEDICAL CENTER POLICY AND PROCEDURE
SUNY DOWNSTATE MEDICAL CENTER POLICY AND PROCEDURE Subject: COMPLIANCE TRAINING Page 1 of 9 No. HIPAA-11 Original Issue Date 2/08 Prepared by: Shoshana Milstein Supersedes: 4/10 Reviewed by: Renee Poncet
More informationHounslow Safeguarding Adults Board Partnership Provider Concerns Terms of Reference
Hounslow Safeguarding Adults Board Partnership Provider Concerns Terms of Reference Jo Carmody Hounslow Safeguarding Adults Board Partnership Approved 30.11.15 Joint Guidance on Quality & Safeguarding
More informationAdvances in B Cell Biology:
R.J. Fasenmyer Center for Clinical Immunology and Phoenix Rheumatology Association Advances in B Cell Biology: RA, SLE, and Vasculitis Saturday, February 18, 2012 Gainey Ranch Golf Club Scottsdale, AZ
More informationAddressing safety concerns about U-500 insulin in a hospital setting
Addressing safety concerns about U-500 insulin in a hospital setting Karen Hamrick Samaan, Megan Dahlke, and Judy Stover U-500 regular insulin has been used since the 1950s to treat diabetic patients with
More informationMarch 2015. Medication Guidelines
March 2015 Medication Guidelines Approved by the College and Association of Registered Nurses of Alberta Provincial Council, March 2015. Permission to reproduce this document is granted. Please recognize
More informationADMINISTRATION OF MEDICATION TO STUDENTS POLICY
CODE: C.009 Program CONTENTS ADMINISTRATION OF MEDICATION TO STUDENTS 1.0 PRINCIPLES 2.0 POLICY FRAMEWORK 3.0 AUTHORIZATION POLICY 1.0 PRINCIPLES 1.1 The primary responsibility for administering medication
More informationFifteenth Annual ASHP Conference for Leaders in Health-System Pharmacy Implementing Medication-Use Systems: Meeting Stakeholders Requirements
Fifteenth Annual ASHP Conference for Leaders in Health-System Pharmacy Implementing Medication-Use Systems: Meeting Stakeholders Requirements CHRISTOPHER URBANSKI, M.S., B.S.PHARM. BARBARA GIACOMELLI,
More informationEnsuring Safe & Efficient Communication of Medication Prescriptions
Ensuring Safe & Efficient Communication of Medication Prescriptions in Community and Ambulatory Settings (September 2007) Joint publication of the: Alberta College of Pharmacists (ACP) College and Association
More informationPhilosophy: Although sample medication may be helpful in patient care, drug samples:
Title: Policy on Sample Medication Policy #: 450.80 Adopted: 1/90, 7/00 Revised: 3/95, 5/98, 7/00, 10/01 Reviewed: 7/00, 10/01, 02/03 This policy is applicable to the following Henry Ford Health System
More informationElectronic Medication Administration Record (emar) (For Cerner Sites Only)
POLICY NO. 1009 Approved: 12/05 Effective: 12/05 Reviewed: 9/10; 5/12 1. Purpose: Electronic Medication Administration Record (emar) (For Cerner Sites Only) To provide direction for the transcription and
More informationObjective. Failure Modes & Effects Analysis: A U-500 Insulin Case Study. What is a FMEA? Assembling a Team. Steps to Conducting a FMEA 5/12/2011
5/12/2011 Objective Failure Modes & Effects Analysis: A U-500 Insulin Case Study Understand the role of a failure mode and effects analysis (FMEA) in developing U-500 insulin use criteria Ryan J. Bickel,
More informationINSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER MEDICATIONS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES APPROVED BY APPLIES
More informationMedications or therapeutic solutions may be injected directly into the bloodstream
Intravenous Therapy Medications or therapeutic solutions may be injected directly into the bloodstream for immediate circulation and use by the body. State practice acts designate which health care professionals
More informationLicensed Pharmacy Technician Scope of Practice
Licensed Scope of Practice Adapted from: Request for Regulation of s Approved by Council April 24, 2015 Definitions In this policy: Act means The Pharmacy and Pharmacy Disciplines Act means an unregulated
More informationPharmacy Technician Structured Practical Training Program Logbook
Pharmacy Technician Structured Practical Training Program Logbook This logbook outlines the activities that pharmacy technician learners are required to complete in order to demonstrate competencies as
More informationPharmacy Technicians: Past, Present and Future. Daina Ojala Seven Oaks General Hospital
Pharmacy Technicians: Past, Present and Future Daina Ojala Seven Oaks General Hospital Pharmacy Welcome Greeting. Pharmacy technicians have had to adapt to many positive changes in their careers. We ll
More informationDIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL P.O. BOX 110806 JUNEAU, ALASKA 99811-0806 ALASKA STATE BOARD OF PHARMACY
DIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL P.O. BOX 110806 JUNEAU, ALASKA 99811-0806 ALASKA STATE BOARD OF PHARMACY Remote Pharmacy Owner Name: DBA Name: Address: Telephone Number: Fax Number:
More informationExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes
ExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes # scored items 1. Regulations and Pharmacy Duties 35 A. Overview of technician
More informationWhat Every Practitioner Needs to Know About Controlled Substance Prescribing
What Every Practitioner Needs to Know About Controlled Substance Prescribing New York State Department of Health Use of Controlled Substances Controlled substances can be effective in the treatment of
More informationStandards of Practice for Pharmacists and Pharmacy Technicians
Standards of Practice for Pharmacists and Pharmacy Technicians Introduction These standards are made under the authority of Section 133 of the Health Professions Act. They are one component of the law
More informationFMEA Failure Risk Scoring Schemes
FMEA Failure Risk Scoring Schemes 1-10 Scoring for Severity, Occurrence and Detection CATEGORY Severity 10 9 8 7 6 5 3 2 1 Hazardous, without warning Hazardous, with warning Very High High Moderate Low
More informationRFID in the Hospital Environment
RFID in the Health Care Industry RFID in the Hospital Environment Speaker: Daniel Engels, Ph.D. Director of Research MIT Auto-ID Labs I. Mun, Ph.D. Director, Bio-Medical Research Aventura Hospital & Medical
More informationMedication Administration for CNAs
Medication Administration for CNAs Two (2.0) contact hours Expiration Date: 12/4/2017 First Published: 12/4/2013 Reproduction and distribution of these materials is prohibited without RN.com content licensing
More informationASHP Guidelines on Home Infusion Pharmacy Services
ASHP Guidelines on Home Infusion Pharmacy Services Practice Settings Guidelines 469 Background and Purpose Background. Home infusion services are provided by a variety of organizations, including hospitals,
More informationEvidence Based Practice Information Sheets for Health Professionals. Strategies to reduce medication errors with reference to older adults
Volume 9, issue 4, 2005 ISSN 1329-1874 BestPractice Evidence Based Practice Information Sheets for Health Professionals Information source Strategies to reduce medication errors with reference to older
More informationMeasurable improvements in medication management
Measurable improvements in medication management system Pyxis We re able to get the meds we need quickly and safely, even after hours. Tammy Hill, RN Critical Care Coordinator Alliance Community Hospital
More informationIntake / Admissions Processes
Intake / Admissions Processes Now that the elements of providing quality customer service have been reviewed, the intake and admission processes will be covered. Some homecare companies make a distinction
More informationMedication Administration and Delegation in Massachusetts Schools Presented by
Medication Administration and Delegation in Massachusetts Schools Presented by Massachusetts Department of Public Health in collaboration with the Northeastern University School Health Institute Massachusetts
More informationPHARMACY TECHNICIAN SERIES
PHARMACY TECHNICIAN SERIES Occ. Work Prob. Effective Last Code No. Class Title Area Area Period Date Action 4058 Pharmacy Technician I 12 446 6 mo. 02/15/04 Revised 4059 Pharmacy Technician II 12 446 6
More informationNSW Adult Subcutaneous Insulin Prescribing Chart User Guide
NSW Adult Subcutaneous Insulin Prescribing Chart User Guide Adult Subcutaneous Insulin Prescribing Chart User Guide - 13 August 2013 Contents Target audience:... 1 Exceptions:... 1 1. Introduction... 2
More informationLiberty Union High School District Administrative Regulation
Page 1 of 7 Definitions Authorized health care provider means an individual who is licensed by the State of California to prescribe or order medication, including, but not limited to, a physician or physician
More informationAPPLICATION FOR PHARMACY PROFESSIONAL LIABILITY INSURANCE
APPLICATION FOR PHARMACY PROFESSIONAL LIABILITY INSURANCE (Claims Made Basis) APPLICANT S INSTRUCTIONS: 1. Answer all questions. If the answer requires detail, please attach a separate sheet. 2. Application
More informationENROLLED ACT NO. 94, HOUSE OF REPRESENTATIVES FIFTY-EIGHTH LEGISLATURE OF THE STATE OF WYOMING 2005 GENERAL SESSION
ENGROSSED AN ACT relating to pharmaceutical drugs; directing the department of health to establish a program for the donation and dispensing of drugs as specified; providing definitions; providing rulemaking
More informationempowersystemstm empowerhis Advanced Core Hospital Information System Technology Comprehensive Solutions for Facilities of Any Size
empowersystemstm empowerhis TM Advanced Core Hospital Information System Technology Comprehensive Solutions for Facilities of Any Size ADT / Patient Registration System + Fully Integrated Patient Registration
More informationPatient Centered Medical Home (PCMH): Communication and Care Coordination
Patient Centered Medical Home (PCMH): Communication and Care Coordination Phillip Roemer, MD Assistant Professor of Medicine General Internal Medicine Feinberg School of Medicine Northwestern University
More informationVERMONT2007. Vermont Prescription Monitoring Program. Report to the Legislature on Act 205 January 15, 2008
VERMONT2007 Vermont Prescription Monitoring Program Report to the Legislature on Act 205 January 15, 2008 108 Cherry Street, PO Box 70 Burlington, VT 05402 1.802.863.7341 healthvermont.gov Vermont Prescription
More informationLORRAINE A. LEE 20 York Street 10 Christina Court 55 PS, LL Clinton, CT 06413 New Haven,CT 06510 (860) 395-4911 (203) 688-8456
LORRAINE A. LEE 20 York Street 10 Christina Court 55 PS, LL Clinton, CT 06413 New Haven,CT 06510 (860) 395-4911 (203) 688-8456 crlee10@comcast.net lorraine.lee@ynhh.org PROFESSIONAL EXPERIENCE: Director,
More informationMARY T. INC. PROGRAM POLICY MANUAL
MARY T. INC. PROGRAM POLICY MANUAL POLICY Safe Medication Assistance and SECTION: 2-2C TITLE: Administration Policy REVISED BY: Jane Strobel, RN PAGE: 1of 6 APPLIES TO: All Services Operating Under Rule
More informationHealthcare at a Crossroads
Healthcare at a Crossroads A Discussion Among Leading IDN Executives Kettering Health Network Steve Huckabaa, Network Vice President Beth Israel Deaconess Medical Center Joe Sheil, Director of Contracting
More informationNOTE: In the event that the seal is accidentally broken, the narcotic may be wasted via narcotic wastage procedures.
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER NARCOTICS AND CONTROLLED DRUGS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES
More informationMEDITECH Immunization Management Choosing the Correct Path for Meaningful Use
MEDITECH Immunization Management Choosing the Correct Path for Meaningful Use Presented by Karl Frohlich Senior Consult, Santa Rosa Consulting Session Overview Meaningful Use Requirements Query/Assessment-Based
More informationROOT CAUSE ANALYSIS (RCA)
ROOT CAUSE ANALYSIS (RCA) Sylvia Hyland, BScPhm Julie Greenall, BScPhm Medication Error Response I should have read the label. This has not happened before. This is unlikely to happen again. Physician
More informationMedicines reconciliation on admission and discharge from hospital policy April 2013. WHSCT medicines reconciliation policy 1
Medicines reconciliation on admission and discharge from hospital policy April 2013 WHSCT medicines reconciliation policy 1 Policy Title Policy Reference Number Medicines reconciliation on admission and
More information11 MEDICATION MANAGEMENT
1 11 MEDICATION MANAGEMENT OVERVIEW OF MEDICATION MANAGEMENT Depending on the size, structure and functions of the health facility, there may be a pharmacy with qualified pharmacists to dispense medication,
More informationInstitute for Safe Medication Practices (ISMP) Guidance on the Interdisciplinary Safe Use of Automated Dispensing Cabinets
20 08 Institute for Safe Medication Practices (ISMP) Guidance on the Interdisciplinary Safe Use of Automated Dispensing Cabinets Table of Contents About ISMP...1 Background on ADC Safety...1 Stakeholder
More informationNH Laws / Rules Regarding Limited Retail Drug Distributors
NH Laws / Rules Regarding Limited Retail Drug Distributors 318:1, VII-a. "Limited retail drug distributor'' means a distributor of legend devices or medical gases delivered directly to the consumer pursuant
More informationINSTITUTE FOR SAFE MEDICATION PRACTICES CANADA
INSTITUTE FOR SAFE MEDICATION PRACTICES CANADA PRIVACY IMPACT ASSESSMENT (PIA) ON ANALYZE-ERR AND CURRENT DATA HANDLING OPERATIONS VERSION 3.0-2 JULY 11, 2005 PREPARED IN CONJUNCTION WITH: ISMP Canada
More informationAchieving safer prescription of cytotoxic agents: Academy recommendations
Achieving safer prescription of cytotoxic agents: Academy recommendations April 2015 Executive Summary Prescribing of cytotoxic drugs, immunosuppressant agents and drugs with a narrow therapeutic index
More informationImplementing Proactive Pharmacogenetic Testing as a Standard of Care
Implementing Proactive Pharmacogenetic Testing as a Standard of Care Submitted by: James M. Hoffman, Pharm.D., MS, BCPS, Medication Outcomes & Safety Officer, Pharmaceutical Services, Associate Member,
More informationADMINISTRATION OF INTRAVENOUS PUSH/DIRECT MEDICATIONS
SASKATOON DISTRICT HEALTH Department of Nursing Affairs ADMINISTRATION OF INTRAVENOUS PUSH/DIRECT MEDICATIONS SPECIAL NURSING PROCEDURE LEARNING PACKAGE This package provides the basic information necessary
More informationIncorporating Pediatric Medication Safety into your Health System
Incorporating Pediatric Medication Safety into your Health System Julie Kasap, Pharm.D. Margaret CHOI Heger, Pharmacy PharmD, Supervisor BCPS January 2015 Pediatric Antimicrobial Stewardship Conference
More information